InflaRx NV (IFRX)
1.41
+0.04
(+2.92%)
USD |
NASDAQ |
May 01, 16:00
1.36
-0.05
(-3.55%)
After-Hours: 20:00
InflaRx Total Assets (Quarterly): 132.88M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 132.88M |
September 30, 2023 | 137.06M |
June 30, 2023 | 144.50M |
March 31, 2023 | 94.12M |
December 31, 2022 | 109.81M |
September 30, 2022 | 109.22M |
June 30, 2022 | 119.74M |
March 31, 2022 | 128.44M |
December 31, 2021 | 141.68M |
September 30, 2021 | 150.06M |
June 30, 2021 | 160.68M |
March 31, 2021 | 172.62M |
December 31, 2020 | 108.50M |
September 30, 2020 | 118.96M |
Date | Value |
---|---|
June 30, 2020 | 116.82M |
March 31, 2020 | 125.21M |
December 31, 2019 | 136.19M |
September 30, 2019 | 154.84M |
June 30, 2019 | 164.77M |
March 31, 2019 | 174.02M |
December 31, 2018 | 182.13M |
September 30, 2018 | 191.30M |
June 30, 2018 | 191.46M |
March 31, 2018 | 143.30M |
December 31, 2017 | 149.02M |
September 30, 2017 | 28.29M |
June 30, 2017 | 30.40M |
December 31, 2016 | 31.21M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
94.12M
Minimum
Mar 2023
172.62M
Maximum
Mar 2021
132.95M
Average
132.88M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
Affimed NV | 107.40M |
MorphoSys AG | 2.240B |
BioNTech SE | 25.43B |
Immatics NV | 563.72M |
CureVac NV | 871.33M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 19.48M |
Shareholders Equity (Quarterly) | 113.39M |
Current Ratio | 6.499 |